Dual SYK/JAK inhibition overcomes ibrutinib resistance in chronic lymphocytic leukemia: Cerdulatinib, but not ibrutinib, induces apoptosis of tumor cells protected by the microenvironment

Ibrutinib (BTK inhibitor) has generated remarkable responses in CLL. However, the drug, to a large extent, does not cause cell death directly and does not eradicate CLL malignant clones. Inability to eradicate CLL has fostered resistance generation. Once patients become resistant, they do poorly wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Ailin, Lu, Pin, Coffey, Greg, Conley, Pamela, Pandey, Anjali, Wang, Y. Lynn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355069/
https://www.ncbi.nlm.nih.gov/pubmed/28088788
http://dx.doi.org/10.18632/oncotarget.14588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355069/
https://www.ncbi.nlm.nih.gov/pubmed/28088788
http://dx.doi.org/10.18632/oncotarget.14588

Ejemplares similares